An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, ...

Although initial attempts to apply this therapeutic strategy in multiple sclerosis, rheumatoid arthritis, and type 1 diabetes met with failure, recent results from clinical studies hold promise ...

The exact cause of type 1 diabetes is unknown. ... Handel A, Handunnetthi L, Ebers G, et al. Type 1 diabetes mellitus and multiple sclerosis: common etiological features.

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, ...

In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...

A new type of "inverse vaccine” has been shown in the lab setting to completely reverse autoimmune diseases like multiple sclerosis and type 1 diabetes, all without shutting down the rest of the ...

It's possible to develop type 1 diabetes in your 20s—or anytime in adulthood. This condition is known as adult-onset type 1 diabetes.

In the U.S., about 1.25 million people are currently living with type 1 diabetes, and about 500,000 of these people are children. Worldwide, type 1 diabetes diagnoses have raised by 200%-300% in ...

TIXiMED is the exclusive license holder for the patent surrounding TIX100, a novel, small molecule TXNIP inhibitor, and its derivatives, which has been shown to protect against models of type 1 ...